期刊文献+

携带Foxp3基因慢病毒载体的构建

Construction of lentiviral vector carrying Foxp3 gene
下载PDF
导出
摘要 目的构建携带叉头样转录因子p3(Foxp3)基因的重组慢病毒载体PWPXL-MOD-Foxp3,并包装成慢病毒,为体外获得CD4+CD2+5调节性T细胞(CD4+CD2+5 Tregs)奠定基础。方法采用双酶切法构建慢病毒表达载体PWPXL-MOD-Foxp3,用磷酸钙沉淀法将包装慢病毒所需的四质粒系统共转染人胚肾细胞293T,慢病毒系统转染48h后收集病毒上清液,纯化、浓缩后采用流式细胞术测定慢病毒滴度。结果重组的慢病毒载体滴度为3.3×108IU/ml。结论成功构建了含有Foxp3基因的高滴度的慢病毒载体,为体外获得CD 4+CD 2+5 Tregs奠定基础。 Objective To construct lentiviral vector carrying Foxp3 gene and packaged in lentivrial particles(PWPXL-MOD-Foxp3),making the basis for obtaining CD+4CD+25 regulatory T cells in vitro.Methods The PWPXL-MOD-Foxp3 expression vector was be constructed by double digests.The recombinant lentiviral vector and else four packaging plasmids were co-transfected into human embroic kidney 293T cells by using calcium phosuhate technique.The supernatant was collected,purified,concentrated,and then,the viral titers were tested by flow cytometer.Result The titer of the lentiviral particles was 3.3×108 IU/ml.Conclusions The high-titer lentvirus vector containing Foxp3 geng is constructed successfully,which will contribute to obtain CD+4CD+25 regulatory T cells in vitro.
出处 《山东医药》 CAS 北大核心 2011年第26期29-31,共3页 Shandong Medical Journal
基金 国家自然科学基金资助项目(30871207) 安徽省科技厅重点科研计划项目(7020304101) 安徽省教育厅重点科研项目(KJ2008A154)
关键词 叉头样转录因子p3基因 慢病毒 CD4+CD2+5调节性T细胞 基因治疗 forkhead box P3 lentiviral CD+4CD+25 regulatory T cells geng therapy
  • 相关文献

参考文献10

  • 1Coffer PJ, Burgering BM. Forkhead-box transcription factors and their role in the immune system [ J ]. Nat Rev Immunol, 2004,4 ( 11 ) :889-899.
  • 2Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3 [ J]. Science, 2003,299 (5609) :1057-1061.
  • 3曹江,陈翀,徐开林,潘秀英,李振宇,曾令宇.携带鼠Foxp3基因的自身失活型慢病毒载体的构建及表达[J].四川大学学报(医学版),2009,40(2):199-202. 被引量:5
  • 4Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3[J]. Nat Immunol, 2005,6(4) :331-337.
  • 5Sakaguchi S. Naturally arising Foxp3-expreessing CD25^+ CD4^+ regulatory T cells in immunological tolerance to self and non-self[ J]. Nat Immunol, 2005,6(4) :345-352.
  • 6Wildin RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy[J]. Nat Genet,2001,27( 1 ) :18-20.
  • 7Walker MR, Kasprewicz D J, C, ersuk VH, et al. Induction of Foxp3 and acquisition of T regulatory activity by stimulated human CD4^+ CD25^+ T cells[J]. J Clin Invest. 2003,112(9) :1437-1443.
  • 8Jaeckel E, von Boehmer H, Manns MP. Antigen-specific Foxp3- transduced T-cells can control established type 1 diabetes[ J]. Diabetes, 2005, 54(2):306-310.
  • 9Long E, Wood led. Understanding Foxp3 : progress towards achieving transplantation tolerance[J]. Transplantation, 2007,84 (4) : 459-461.
  • 10Akl A, Luo S, Wood KJ, et al. Induction of transplantation tolerance-the potential of regulatory T cell [ J ]. Transpl Immunol, 2005,14(3-4) :225-230.

二级参考文献11

  • 1Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol,2007,7(8) :585-598.
  • 2Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self- tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains ( CD25 ). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 1995 ) 155 (3) : 1151-1164.
  • 3Gavin MA, Rasmussen JP, Fontenot JD, et al. Foxp3- dependent programme of regulatory T-cell differentiation. Nature, 2007 , 445 (7129) :771-775.
  • 4Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4^+ CD25^+ regulatory T cells. Nat Immunol,2003 ,4(4) ; 330-336.
  • 5Williams LM, Rudensky AY. Maintenance of the Foxp3- dependent developmental program in mature regulatory T ceils requires continued expression of Foxp3. Nat Immunol, 2007 , 8 (3) :277-284.
  • 6Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science,2003 299(5609) : 1057-1061.
  • 7Lin CH, Hunig T. Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur J Immunol, 2003;33(3) :626-638.
  • 8Hoffmann P, Eder R, Kunz-Schughart LA, et al. Large-scale in vitro expansion of polyelonal human CD4^+ CD25^high regulatory T cells. Blood, 2004,104(3) : 895-903.
  • 9Fantini MC, Becker C, Monteleone G, et al. Cutting edge: TGF-beta induces a regulatory phenotype in CD4^+ CD25^- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol,2004, 172(9) :5149-5153.
  • 10Albert MH, Liu Y, Anasetti C, et al. Antigen-dependent suppression of alloresponses by Fo:rp3-induced regulatory T cells in transplantation. Eur J Immunol, 2005; 35 (9): 2598- 2607.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部